00:00:28    	Executive Summary

00:16:11      	1. Purpose and Scope

00:17:02    	2. Introduction and background epidemiology

00:21:57   	3. Identification and assessment of evidence

00:23:44    	4. Clinical issues
00:23:47    	4.1. Can women at risk of collapse be identified early?
00:29:15    	4.2. What are the causes of maternal collapse?
00:31:13     	4.2.1. Haemorrhage
00:32:40    	4.4.2. Thromboembolism
00:33:21     	4.2.3. Amniotic fluid embolism
00:36:03    	4.2.4. Cardiac Disease
00:38:43    	4.2.5. Sepsis
00:39:34     	4.2.6. Drug toxicity and overdose
00:42:01     	4.2.7. Eclampsia
00:42:41     	4.2.8. Intracranial haemorrhage
00:43:09    	4.2.9. Anaphylaxis
00:46:03   	4.2.10. Other causes

00:47:01   	4.3. What are the physiological and anatomical changes in pregnancy that affect resuscitation?
00:48:45   	4.3.1. Aortocaval compression
00:50:36   	4.3.2. Respiratory changes
00:51:54    	4.3.3. Intubation
00:52:33   	4.3.2. Aspiration 
00:53:51   	4.3.5. Circulation 

00:55:02   	4.4. What is the optimal initial management of maternal collapse?
00:55:10   	4.4.1. Resuscitation in maternal collapse
01:00:00   	4.4.2 Relieving aorto-caval compression
01:03:58   	4.4.3 Airway
01:07:11	     	4.4.4 Breathing
01:08:58	     	4.4.5 Circulation
01:15:25	     	4.4.6 Drugs
01:15:47	     	4.4.7 Other considerations

01:16:59	     	4.5 When, where and how should perimortem caesarean section (PMCS) be performed?

01:25:27	     	4.6 What does the ongoing management consist of?
01:26:47	     	4.6.1 Haemorrhage
01:29:31	     	4.6.2 Venous thromboembolism
01:30:36	     	4.6.3 Amniotic fluid embolism
01:34:28	     	4.6.4 Cardiac disease
01:35:44	     	4.6.5 Sepsis
01:39:48	     	4.6.6 Drug overdose and toxicity
01:40:27	     	4.6.6.1 Magnesium sulphate
01:41:23	     	4.6.6.2 Local anaesthetic agents
01:46:18	     	4.6.7 Eclampsia
01:46:58	     	4.6.8 Intracranial haemorrhage
01:47:54 	4.6.9 Anaphylaxis

01:50:29	     	4.7 What are the outcomes for mother and baby?

01:57:28	     	4.8 Who should be on the team?

02:00:59	5 Clinical governance
02:01:03 	5.1 Documentation
02:02:05 	5.2 Incident reporting
02:03:57 	5.3 Training
02:07:27 	5.4 Debriefing

02:08:26 	6 Recommendations for future research

02:09:01 	7 Auditable topics

02:10:05 	8 Useful links and support groups

02:12:04  	Disclosures of interest

02:12:15     	Funding

02:13:13	     	Appendix 1: Explanation of guidelines and evidence levels
	
02:14:35	     	Appendix 2: Causes of maternal collapse
	
02:17:04	     	Appendix 3: Physiological and physical changes in pregnancy
	
02:20:52  	Appendix 4: Maternal collapse algorithm
	
02:21:23  	Appendix 5: Recommended airway equipment
	
02:21:57 	     	Appendix 6: Post collapse management
	
02:22:25	     	References

Green-top Guideline no. 56 Maternal Collapse in Pregnancy and the Puerperium

The aim of this guideline is to provide evidence-based recommendations on the use of antenatal corticosteroids in women at risk of preterm birth or undergoing caesarean birth at term.

1:  Key Recommendations (00:50)
2: Background and Scope (03:46 )
3: Identification and Assessment of Evidence (06:27)
4: The Benefits of Antenatal Corticosteroids (07:30)
4.1: What are the benefits of corticosteroids in preterm labour and birth (07:35)
4.2 What are the benefits of corticosteroids in planned caesarean birth at term (10:04)
Table 1: Risks and benefits of antenatal corticosteroids to be discussed and offered (16:46)
5: At what gestation should antenatal corticosteroids be discussed and offered (27:03)
6: In what particular circumstances would antenatal corticosteroids be discussed with and offered to women? (34:43)
6.1: Multiple pregnancy (34:54)
6.2 Women with diabetes mellitus (39:03)
6.3 Pregnancies complicated by fetal growth restriction, pre-eclampsia or antepartum haemorrhage (43:11)
6.4. Preterm, prelabour rupture of membranes (PPROM) (51:17)
7: What is the optimum dose and route of administration for a course of antenatal corticosteroids? (55:46)
Betamethasone (58:44 )
Dexamethasone (1:01:00)
8: How long after administration is a course of antenatal corticosteroids most effective? (1:05:40)
9: What are the risks associated with the administration of antenatal corticosteroids? (1:17:50)
9.1: What are the risks to the woman? (1:19:00)
9.2: What are the risks to the baby? (1:20:53)
10 - What are the contraindications to the use of antenatal corticosteroids? (1:31:44 )
11 - In what circumstances should an antenatal course of corticosteroids be repeated? (1:33:31)
12. Recommendations for future research (1:37:21)
13. Auditable topics (1:38:37)
Closing Statement (1:39:52)

Green-top Guideline no. 74 Antenatal corticosteroids to reduce neonatal morbidity and mortality

MP3 Audio Version of Green-top Guideline No. 75, Cervical Cerclage, published February 2022

The purpose of this guideline is to review the literature and provide evidence-based guidance on the use of cerclage in women at risk of preterm birth and second trimester loss.

1. Key recommendations (0:35)
2. Background and scope (03:03)
3. Identification and assessment of evidence (05:35)
4. Definitions (07:30)
5. History-indicated cerclage (11:14)
6. Ultrasound-indicated cerclage (16:54)
6.1. When should an ultrasound-indicated cerclage be offered? (16:58)
6.1.1 Women with a singleton pregnancy and a history of spontaneous second trimester loss or preterm birth (19:45)
6.2. Who should be offered serial sonographic surveillance with a view to ultrasound-indicated cerclage? (24:19)
7. Can cervical cerclage be recommended in any other groups of women considered at increased risk of preterm birth (29:50)
7.1. Multiple pregnancy (30:00)
7.2. Cervical surgery, trauma and uterine abnormalities (35:57)
7.3. Women with raised BMI (43:43)
8. Transabdominal cerclage (45:09)
8.1. When should a transabdominal cerclage be considered? (45:14)
8.2. Should a transabdominal cerclage be performed laparoscopically? (50:06)
8.3. How should women who experience delayed miscarriage or fetal death be cared for? (53:08)
9. Emergency cerclage (55:19)
9.1. When should a rescue cerclage be discussed and considered? (55.22)
9.2. What are the contraindications to cerclage insertion? (1:00:39)
9.3. What information should be given to women before cerclage insertion? (1:01:28)
10. Pre-operative management (1:08:00)
10.1. What investigations should be performed before insertion of cervical cerclage? (1:08:04)
10.2. Should amniocentesis to detect infection be performed before rescue or ultrasound-indicated cerclage? (1:10:53)
10.2.1. Is amnioreduction before emergency cerclage recommended? (1:14:23)
10.2.2. Should a latency period be observed between presentation and insertion of a rescue or ultrasound-indicated cerclage? (1:15:20)
10.2.3. Should routine genital tract screening for infection be carried out before cerclage insertion? (1:16:17)
11. Operative issues (1:17:35)
11.1. Should perioperative tocolysis be used for insertion of cerclage? (1:17:39)
11.2. Should perioperative antibiotics be given? (1:19:11)
11.3. What method of anaesthesia should be employed for the insertion of cerclage? (1:20:31)
11.4. Can cerclage be performed as a day-case procedure? (1:21:53)
11.5. Which technique and material should be used? (1:22:58)
12. Adjuvant management (1:28:53)
12.1. Bed rest (1:28:56)
12.2. Sexual intercourse (1:30:36)
12.3. Is there a role for post-cerclage serial sonographic surveillance of cervical length? (1:31:15)
12.4. Is fetal fibronectin testing useful following insertion of a cervical cerclage? (1:35:07)
12.5. Should women receive supplement progesterone following cerclage? (1:37:38)
12.6. Should women be offered Arabin pessary or progesterone instead of cerclage? (1:40:44)
13. When should the cerclage be removed? (1:44:39)
13.1. Should the cerclage be removed following PPROM? (1:47:30)
14. Recommendations for future research (1:50:28)
15. Suggested audit topics (1:51:25)
Closing statement (1:52:05)

Green-top Guideline No. 75 Cervical Cerclage

The RCOG podcast discusses living with fibroids. This condition affects 2 in 3 women, and, for some people they can really impact their lives. Dr Karen Joash discusses diagnosis, treatment and impact with Gochi Nwulu about living with this painful condition

RCOG Podcast – Episode 1: Fibroids

This information is for you if you have been told you may have endometriosis.

Links to further information are available on the RCOG website: https://www.rcog.org.uk/for-the-public/browse-our-patient-information/endometriosis/

Endometriosis

This information is for you if you are pregnant and are thinking of travelling by air.

Links to further information are available on the RCOG website: https://www.rcog.org.uk/for-the-public/browse-our-patient-information/air-travel-and-pregnancy/

Air travel and pregnancy

In our first episode the surgical skills fellows (Hannah Pierce & Naomi Harvey) talk to RCOG president, Ranee Thakar, and RCOG Vice-president for education, Ian Scudamore, on how the surgical skills project came to be and their own personal experiences of surgical skills training. The following bitesize episodes will do a deeper dive into each of the five chapters of the surgical skills interim report. Highlighting the key findings and generating conversation on some of the potential solutions to be taken forward in the next phase of the project

Episode 1: Knot to be missed: the RCOG surgical skills podcast - introduction

Episode 6: Knot to be missed: the RCOG surgical skills podcast - investing in the educators

In this episode, we discuss the fourth focus of the Surgical Skills project- Lifelong learning - and what we will be working on in the next phase of the project. 

New consultants and specialists often face the challenge of continuing their surgical skills acquisition in an environment where surgical opportunities may belimited by clinical responsibilities, rota pressures and increasing patient demands. Protected time and support are required for ongoing surgical skills maintenance and development. The next phase of the project will explore the role of fellowships.

Episode 5: Knot to be missed: the RCOG surgical skills podcast - lifelong learning

Episode 3: Knot to be missed: the RCOG surgical skills podcast - simulation and virtual learning

Our future workforce faces significant challenges in meeting the demands of an evolving healthcare landscape and the increasing complexity of patient needs. We must be strategic in supporting our workforce to match changing trends bу developing strong progressive career support for each resident doctor and ensuring we proactively develop a workforce capable of managing increased surgical complexity. 

In this episode, we discuss the first focus of the Surgical Skills project- Workforce of the future- and what we will be working on in the next phase of the project.

Episode 2: Knot to be missed: the RCOG surgical skills podcast - workforce of the future

Long gynaecology waiting lists, workforce shortages and the increasing complexity of surgeries have limited residents' exposure to surgical skills practice and training. We need to reprioritise surgical training through earlier focus on endoscopic training. by increasing adaptability in training and through investment in innovative technologies that support residents in accessing training opportunities. Simulation training has become a vital tool for surgical skills acquisition, providing a safe, controlled environment where doctors can practice procedures without risking patient safety. We will examine how we can embed simulation training into the RCOG curriculum and will establish a Simulation Working Group to ensure equal access to training. 

In this episode, we discuss the third focus of the Surgical Skills project- Re-prioritising surgical training - and what we will be working on in the next phase of the project.

Episode 4: Knot to be missed - The RCOG Surgical Skills Podcast - Reprioritising surgical training

Episode 7: Knot to be missed: the RCOG surgical skills podcast - laparoscopic simulation training

In this episode of Knot to be Missed: the RCOG Surgical Skills Podcast, hosts Hannah Pierce and Naomi Harvey are joined by Miss Nahid Gul, a leading consultant in gynaecological pelvic laparoscopic and robotic surgery. Together, they explore Miss Gul’s inspiring career journey—from her early days in obstetrics and gynaecology to her pioneering work in minimally invasive and robotic surgery. With insights into training, mentorship, and the evolving future of surgical practice in the UK, this conversation offers a compelling look at innovation, leadership, and the transformative potential of technology in women's health.

Episode 8: Knot to be Missed: RCOG surgical skills podcast: The rise of the robot

Episode 9: Knot to be Missed: RCOG surgical skills podcast: serving up the future of training

Episode 10: Knot to be missed: the RCOG Surgical Skills Podcast - incivility in surgery

Episode 11: Knot to be missed: the RCOG Surgical Skills Podcast - mind the gap

Episode 12: Knot to be missed: the RCOG Surgical Skills podcast - beyond the knot

Episode 13: Knot to be missed: the RCOG Surgical Skills podcast - view from across the pond

Episode 14: Knot to be missed: the RCOG Surgical Skills podcast - the great surgical heist

Episode 15: Knot to be missed: the RCOG Surgical Skills podcast - Ranee Thakar reflection

Birth Options After Previous Caesarean Section

Ectopic pregnancy

Heavy bleeding after birth (post partum haemorrhage)

Treatment for symptoms of the menopause

Placenta praevia, placenta accreta and vasa praevia

This guideline comprises recommendations relating to the diagnosis, assessment, care and timing of birth of women presenting with suspected PPROM from 24+0 to 36+6 weeks of gestation. It also addresses care in a subsequent pregnancy.

1.  Key recommendations (01:07)

2.  Background and scope (03:35)

3.  Identification and assessment of evidence (04:45)

4. Diagnosis (05:27)

4.1 How is the diagnosis of PPROM made? (05:30)

5.  Assessment (10:54)

5.1  What is required antenatally to identify infection? (10:58)

5.2  Should neonatologists be included in the woman's care? (15:10)

6.  Management (16:58)

6.1  Should antibiotics be given? (17:00)

6.2  What is the role of antenatal corticosteroids? (20:09)

6.3  What is the role of magnesium sulfate for neuroprotection of the baby? (25:30)

6.4  Should tocolytic agents be used? (28:17)

6.5  Can women be monitored at home? (30:22)

6.6  Is there a role for amnioinfusion in PPROM? (35:35)

6.7  Should women with PPROM be offered emotional support? (37:34)

7.  Birth (39:02)

7.1  When is the appropriate time to deliver the baby? (39:05)

8.  Care in a subsequent pregnancy following PPROM (44:26)

8.1  Who should care for a the woman in a subsequent pregnancy? (44:32)

9.  Recommendations for future research (46:45)

10.  Auditable topics (47:49)

Disclosures of interest (49:18)

Funding (49:35)

Supporting information (50:13)

References (51:03)

GTG 73: Care of Women Presenting with Suspected PPROM from 24+0 Weeks of Gestation

This information is for you if you have been diagnosed with molar pregnancy or another type of gestational trophoblastic disease (GTD). Molar pregnancy is one of a number of different conditions that are called gestational trophoblastic disease (GTD). These rare conditions happen when a pregnancy does not develop normally from the very beginning.

This information may also be helpful if you are a partner, relative or friend of someone in this situation.

Molar Pregnancy And Gestational Trophoblastic Disease Audio

Evidence based information for the public from the Royal College of Obstetricians & Gynaecologists.

RCOG

Popular tracks